Clinical Trial Update: Trial of an Inactivated Chikungunya Virus Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 trial of an inactivated Chikungunya virus vaccine conducted by Najit Technologies has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Fever

Drugs mentioned

• Inactivated Chikungunya Virus Vaccine

Snippet

Sponsor: Najit Technologies, Inc. | Conditions: Chikungunya Fever, Chikungunya Virus | Phase 1 | Status: COMPLETED